- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/12 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals containing only hydrogen and carbon atoms
Patent holdings for IPC class C07D 263/12
Total number of patents in this class: 20
10-year publication summary
|
3
|
2
|
5
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takasago International Corporation | 407 |
3 |
| University of Kwazulu-natal | 45 |
2 |
| AstraZeneca AB | 2817 |
1 |
| Allergan, Inc. | 2155 |
1 |
| Bayer Cropscience AG | 1833 |
1 |
| Massachusetts Institute of Technology | 10290 |
1 |
| The Board of Trustees of the University of Illinois | 2755 |
1 |
| Argenta Discovery Ltd. | 31 |
1 |
| Epitech Group S.r.l. | 20 |
1 |
| Georgetown University | 631 |
1 |
| JNC Corporation | 1555 |
1 |
| Zhejiang University | 3469 |
1 |
| Zhen Ding Technology Co., Ltd. | 49 |
1 |
| Compagnie Generale des Etablissements Michelin | 4979 |
1 |
| SK Materials JNC Co., Ltd. | 47 |
1 |
| Solesis, Inc. | 8 |
1 |
| Sphenotech Co., Limited | 1 |
1 |
| Other owners | 0 |